Showing results (2171-2180 of 3,022) with videos related to

Sort By:
Pageof 303
The Journal of Infection|May 16, 2021
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative reviewEleni Korompoki, Maria Gavriatopoulou, Rachel S Hicklen, et al.
Journal of Clinical Medicine|September 10, 2021
Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study GroupJelena Bila, Eirini Katodritou, Margarita Guenova, et al.
British Journal of Cancer|May 4, 2026
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosisKonstantinos Soureas, Panagiotis Malandrakis, Maria-Alexandra Papadimitriou, et al.
Archives of Medical Sciences. Atherosclerotic Diseases|February 26, 2025
Cardiac complications of arteriovenous access: a narrative review from a multidisciplinary team perspectiveMelina Stathopoulou, Andreas Tsimpoukis, Konstantinos Tasios, et al.
British Journal of Haematology|June 2, 2020
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemicEfstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, et al.
Blood|January 12, 2011
Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemiaSandra Grass, Klaus-Dieter Preuss, Alexandra Wikowicz, et al.
Nature Communications|July 27, 2018
A mosquito salivary gland protein partially inhibits Plasmodium sporozoite cell traversal and transmissionTyler R Schleicher, Jing Yang, Marianna Freudzon, et al.
Blood|September 19, 2008
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposureMichael Wang, Meletios A Dimopoulos, Christine Chen, et al.
American Journal of Hematology|August 29, 2013
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation: final results on 205 patients of the Greek myeloma study groupEvangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, et al.
JCI Insight|May 22, 2026
Hemodynamic and metabolomic responses to infusion of GLP-1 agonist exenatide in pulmonary arterial hypertensionChinthaka B Samaranayake, Marili Niglas, Nicoleta Baxan, et al.
Pageof 303